Abinash C. Roy,
MD
Languages Spoken: Bengali, English, Hindi
Abinash C. Roy, M.D., FASN., is a Clinical Associate Professor of Medicine, at the University of Utah. As a nephrologist and specialist of clinical hypertension, his clinical interests include Chronic Kidney Disease including all modalities of Renal replacement therapy, Hypertension, Kidney Stone disease, Fluid -Electrolytes abnormalities and Primary Renal Diseases.
Dr. Roy received his Medical Degree from the University of Chittagong in Bangladesh in 1979. He received training in Internal Medicine from Maimonides Medical Center (State University of New York Program) in Brooklyn, New York. He went to Brown University at Providence, Rhode Island for fellowship in Nephrology and Hypertension. Upon completion of the fellowship he joined the division of Nephrology and Hypertension, Department of Medicine at the University of Utah. He is one of the 1st certified specialists in Clinical Hypertension in USA and Canada.
Dr. Roy is Board certified and recently recertified in Internal Medicine and Nephrology.
In addition to the University of Utah Hospitals and Clinics, he has staff privilege in Dixie Regional Medical Center, St George, Utah, Valley View Hospital, Cedar City Utah and Mesa View General Hospital, Mesquite, Nevada.
He currently serves as the Medical Director of Dixie and Desert Valley Dialysis Center of the University of Utah. He runs clinics in southern Utah and Mesquite, Nevada. He provides in-patient acute care nephrology service at Dixie Regional Medical Center, St. George, Utah.
Clinical Locations
Desert Valley Nephrology
435-673-3556
Fax: (435) 656-3968
435-673-3556
Fax: (435) 656-3968
Specialties
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Nephrology |
Abinash C. Roy, M.D., FASN., is a Clinical Associate Professor of Medicine, at the University of Utah. As a nephrologist and specialist of clinical hypertension, his clinical interests include Chronic Kidney Disease including all modalities of Renal replacement therapy, Hypertension, Kidney Stone disease, Fluid -Electrolytes abnormalities and Primary Renal Diseases.
Dr. Roy received his Medical Degree from the University of Chittagong in Bangladesh in 1979. He received training in Internal Medicine from Maimonides Medical Center (State University of New York Program) in Brooklyn, New York. He went to Brown University at Providence, Rhode Island for fellowship in Nephrology and Hypertension. Upon completion of the fellowship he joined the division of Nephrology and Hypertension, Department of Medicine at the University of Utah. He is one of the 1st certified specialists in Clinical Hypertension in USA and Canada.
Dr. Roy is Board certified and recently recertified in Internal Medicine and Nephrology.
In addition to the University of Utah Hospitals and Clinics, he has staff privilege in Dixie Regional Medical Center, St George, Utah, Valley View Hospital, Cedar City Utah and Mesa View General Hospital, Mesquite, Nevada.
He currently serves as the Medical Director of Dixie and Desert Valley Dialysis Center of the University of Utah. He runs clinics in southern Utah and Mesquite, Nevada. He provides in-patient acute care nephrology service at Dixie Regional Medical Center, St. George, Utah.
Academic Locations
Research Statement
My research focuses on Chronic Kidney Disease(CKD) in the setting of rural USA, I.e. prereferral care of CKD in rural USA; prevalence, treatment and control of hypertension in CKD; CKD in Native Americans and progession of CKD.
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Nephrology |
Research Interests
- Disease Progression
- Anemia
- Renal Dialysis
- Anemia of CKD
- Progression of Chronic Kidney Disease
- CKD Progression
Education History
| Fellowship | Rhode Island Hospital/Brown University Neph-Hypertension Fellow, 2001 |
| Residency | Maimonides Medical Center Internal Medicine Resident, 1999 |
| Internship | Maimonides Medical Center Internal Medicine Intern, 1997 |
| Professional Medical | Chittagong Medical College Medicine M.B.B.S., 1979 |
Selected Publications - Journal Articles
Journal Article
- Beddhu S, Filipowicz R, Wang B, Wei G, Chen X, Roy AC, DuVall SL, Farrukh H, Habib AN, Bjordahl T, Simmons DL, Munger M, Stoddard G, Kohan DE, Greene T, Huang Y (2016). A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy. Can J Kidney Health Dis, 3, 2054358116675343.
- Biswas P, Roy AC (2005). Hepatocyte growth factor induces an endothelin-mediated decline in glomerular filtration rate. Am J Physiol, 288, F8-F15.
Abstract
- Roy AC, Biard BC, Williams S, Clark A (2007). Prevalence, Treatment and Control of Hypertension in Diabetic Chronic Kidney Disease in rural United States. [Abstract]. J AM Soc Nephrol, 18(Abstract), 539A.
- Roy AC, Baird BC, Williams S, Carol B (2007). Prevalence, Treatment and Control of Hypertension in Non-Diabetic Chronic Kidney Disease in rural United States. [Abstract]. J Am Soc Nephrol, 18(Abstract), 539A-539A.
- Roy AC, Bullard C, Williams S (2006). Pre-referral Care of Chronic Kidney Disease in Rural United States. [Abstract].
- Roy AC, Baird BC, Williams S, Bullard C (2006). Treatment and Control of Hypertension in Chronic Kidney Disease in Rural United States [Abstract].
- Roy AC, Baird BC, Williams S (2006). Progression of Chronic Kidney Disease in Paiute Indians. [Abstract].
- Roy AC, Baird BC, Williams S, Bullard C (2006). Prevalence and Predictors of Hypertension in Chronic Kidney Disease in Rural United States. [Abstract].
- Roy AC, Baird BC, Williams SJ (2005). Correction of Anemia is Not Associated is not Associated with Slower progression of Chronic Kidney Disease. [Abstract].
- Roy AC, Baird BC, Williams SJ (2005). Long Term Use of Recombinant Human Erythropoietin Slows the Progression of Chronic Kidney Disease. [Abstract]. 16(892A).
- Roy AC, Tolbert E, Centracchio J, Yango A, Dworkin LD (2001). Hepatocyte Growth Factor Induces Endothelin Mediated Decline in Renal Plasma Flow and Glomerular Filtration Rate in Rat [Abstract]. 2001 World Congress of Nephrology.
Global Impact
Education History
| Professional Medical | Chittagong Medical College Medicine M.B.B.S. |